New Delhi, Jan. 16 -- Contrary to the approval given by the country's top drug regulator which said that Hyderabad-based Bharat Biotech's Covaxin could be administered to those above 12 years of age, the Union Health Ministry, in a recent communique, has said that both shots are recommended and approved for people above 18 years of age.
Sources said that the Ministry, in a letter issued on January 14, provided comparative details of the two vaccines - Bharat Biotech's Covaxin and University of Oxford-AstraZeneca's Covishield which is being manufactured by Serum Institute of India - approved by Drug Controller General of India (DCGI).
The factsheet has details of the vaccines, which will be distributed to cold chain points and vaccination ...